Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and External Validation of a Model to Predict Overall Survival in Patients With Resected Gallbladder Cancer.
de Savornin Lohman EAJ, de Bitter TJJ, Hannink G, Wietsma MFT, Vink-Borger E, Nagtegaal ID, Hugh TJ, Gill AJ, Bhimani N, Ahadi MS, van der Post RS, de Reuver PR. de Savornin Lohman EAJ, et al. Among authors: de bitter tjj. Ann Surg. 2023 Apr 1;277(4):e856-e863. doi: 10.1097/SLA.0000000000005154. Epub 2021 Aug 13. Ann Surg. 2023. PMID: 34387199
Exploring the potential of circulating tumour DNA to monitor treatment response in salivary duct carcinoma patients of the CABO-ASAP trial.
Weijers JAM, de Bitter TJJ, Verhaegh GW, van Boxtel W, Uijen MJM, van Engen-van Grunsven ACH, Driessen CML, Schalken JA, Ligtenberg MJL, van Herpen CML. Weijers JAM, et al. Among authors: de bitter tjj. Oral Oncol. 2023 Dec;147:106620. doi: 10.1016/j.oraloncology.2023.106620. Epub 2023 Nov 6. Oral Oncol. 2023. PMID: 37939426 No abstract available.
Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups.
van Ravensteijn SG, Versleijen-Jonkers YMH, Hillebrandt-Roeffen MHS, Weidema ME, Nederkoorn MJL, Bol KF, Gorris MAJ, Verrijp K, Kroeze LI, de Bitter TJJ, de Voer RM, Flucke UE, Desar IME. van Ravensteijn SG, et al. Among authors: de bitter tjj. Cancers (Basel). 2022 Nov 30;14(23):5938. doi: 10.3390/cancers14235938. Cancers (Basel). 2022. PMID: 36497420 Free PMC article.
Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients.
de Bitter TJJ, de Reuver PR, de Savornin Lohman EAJ, Kroeze LI, Vink-Börger ME, van Vliet S, Simmer F, von Rhein D, Jansen EAM, Verheij J, van Herpen CML, Nagtegaal ID, Ligtenberg MJL, van der Post RS. de Bitter TJJ, et al. NPJ Precis Oncol. 2022 Nov 5;6(1):83. doi: 10.1038/s41698-022-00327-y. NPJ Precis Oncol. 2022. PMID: 36335173 Free PMC article.
Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020.
Kooijman JJ, van Riel WE, Dylus J, Prinsen MBW, Grobben Y, de Bitter TJJ, van Doornmalen AM, Melis JJTM, Uitdehaag JCM, Narumi Y, Kawase Y, de Roos JADM, Willemsen-Seegers N, Zaman GJR. Kooijman JJ, et al. Among authors: de bitter tjj. Front Oncol. 2022 Sep 14;12:953013. doi: 10.3389/fonc.2022.953013. eCollection 2022. Front Oncol. 2022. PMID: 36185300 Free PMC article.
Metastasis in the gallbladder: does literature reflect reality?
de Bitter TJJ, Trapman DM, Simmer F, Hugen N, de Savornin Lohman EAJ, de Reuver PR, Verheij J, Nagtegaal ID, van der Post RS. de Bitter TJJ, et al. Virchows Arch. 2022 Jun;480(6):1201-1209. doi: 10.1007/s00428-022-03314-7. Epub 2022 Mar 31. Virchows Arch. 2022. PMID: 35357569 Free PMC article. Review.
15 results